Announced
Synopsis
Dechra, a veterinary products firm, agreed to acquire Piedmont Animal Health, a provider of pharmaceutical services, for $210m. The deal accelerates the provision of innovative solutions to veterinarians and pet owners in areas of unmet or under serviced medical needs. Novel pipeline is complementary to Dechra's existing CAP portfolio, provide the opportunity to significantly strengthen Dechra's presence in key therapeutic areas of dermatology, pain management and anti-infectives. While initial product registrations will be focused on the key North American and European markets, there is the opportunity over time to register products in international markets; and adds strength and expertise to the Company's existing product development resource.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.